SYNAGIS 50 mg/0,5 ml, solution injectable

Business Listing - September 04, 2021

SYNAGIS 50 mg/0,5 ml, solution injectable

SYNAGIS 50 mg/0,5 ml, solution injectable solution injectable intramusculaire Autorisation active Procédure centralisée Commercialisée 8/22/2014 ASTRAZENECA AB

Tags & Categories

active solution injectable autorisation procédure commercialisée intramusculaire centralisée astrazeneca synagis

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business